bufalin has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Kim, NY; Kim, S; Lee, C; Suh, YA | 1 |
Dai, X; Huang, X; Liu, Y; Liu, Z; Wang, L; Xiang, Y; Xu, L; Yang, L; Zhao, C; Zhao, H; Zhou, F; Zhuang, Y | 1 |
Jin, J; Qin, H; Wang, K; Xin, X; Yao, Z | 1 |
Cao, F; Cui, YH; Kang, XH; Kou, WZ; Lu, P; Miao, ZH; Wang, LF; Wang, Y; Xu, ZY; Zhang, JH; Zhang, QQ | 1 |
Cao, F; Gong, YB; Kang, XH; Liao, MJ; Lu, ZH; Miao, ZH; Wang, Y; Xu, ZY; Zhao, KL | 1 |
Deng, HB; Gong, YB; Kang, XH; Wang, LF; Wang, ZQ; Wu, J; Xu, ZY; Zhao, XZ | 1 |
Li, E; Liu, Y; Wang, K; Yu, Y; Zhu, Z | 1 |
7 other study(ies) available for bufalin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Axl Receptor Tyrosine Kinase; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Small Interfering; Transcription, Genetic | 2020 |
Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Enzyme Inhibitors; Female; G2 Phase Cell Cycle Checkpoints; Heterografts; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Molecular Docking Simulation; Prodrugs; Rats; RNA, Small Interfering; STAT3 Transcription Factor | 2021 |
Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
Topics: A549 Cells; Animals; Antineoplastic Agents; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; MicroRNAs; RNA, Circular; Xenograft Model Antitumor Assays | 2021 |
Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
Topics: Apoptosis; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Enzyme Activation; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Proteolysis | 2017 |
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer.
Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Bufanolides; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Genes, erbB-1; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation | 2019 |
[Effect of bufalin combined gefitinib on lung cancer H1975 cells and its mechanisms research].
Topics: Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction | 2013 |
[Effect of Bufalin on proliferation and apoptosis of human non-small cell lung cancer A549 cell].
Topics: Animals; Apoptosis; Bufanolides; Bufonidae; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms | 2010 |